Salou Marion, Nicol Bryan, Garcia Alexandra, Laplaud David-Axel
UMR 1064, INSERM , Nantes , France ; Medicine Department, Nantes University , Nantes , France.
UMR 1064, INSERM , Nantes , France ; ITUN, Nantes Hospital , Nantes , France.
Front Immunol. 2015 Nov 26;6:604. doi: 10.3389/fimmu.2015.00604. eCollection 2015.
Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system characterized by focal demyelination patches associated with inflammatory infiltrates containing T lymphocytes. For decades, CD4(+) T cells have been recognized as playing a major role in the disease, especially in animal models, which has led to the development of several therapies. However, interest has recently developed in the involvement of CD8(+) T cells in MS following the analysis of infiltrating T cells in human brain lesions. A broad range of evidence now suggests that the pathological role of this T cell subset in MS may have been underestimated. In this review, we summarize the literature implicating CD8(+) T cells in the pathophysiology of MS. We present data from studies in the fields of genetics, anatomopathology and immunology, mainly in humans but also in animal models of MS. Altogether, this strongly suggests that CD8(+) T cells may be major effectors in the disease process, and that the development of treatments specifically targeting this subset would be germane.
多发性硬化症(MS)是一种中枢神经系统的慢性自身免疫性疾病,其特征为局灶性脱髓鞘斑块,伴有含有T淋巴细胞的炎性浸润。几十年来,CD4(+) T细胞在该疾病中一直被认为起着主要作用,尤其是在动物模型中,这促使了多种治疗方法的研发。然而,在对人类脑损伤中浸润的T细胞进行分析后,近来人们开始关注CD8(+) T细胞在MS中的作用。现在大量证据表明,这一T细胞亚群在MS中的病理作用可能被低估了。在本综述中,我们总结了涉及CD8(+) T细胞在MS病理生理学中作用的文献。我们展示了遗传学、解剖病理学和免疫学领域的研究数据,主要来自人类研究,但也包括MS动物模型的研究数据。总体而言,这有力地表明CD8(+) T细胞可能是疾病进程中的主要效应细胞,并且开发专门针对该亚群的治疗方法将是恰当的。